financetom
Business
financetom
/
Business
/
Salesforce's Fiscal Q1 Seen Not Catalyzing New Opinions on Stock, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Salesforce's Fiscal Q1 Seen Not Catalyzing New Opinions on Stock, Oppenheimer Says
May 26, 2025 12:37 PM

10:31 AM EDT, 05/22/2025 (MT Newswires) -- Salesforce's ( CRM ) upcoming fiscal Q1 print may not catalyze new opinions on its stock as a material change to the company's estimates after the earnings update is not expected, Oppenheimer said in an earnings preview Thursday.

Ahead of the release of the company's quarterly results on Wednesday, the firm also noted the higher execution risk this fiscal year due to the macro disruption and various leadership changes.

Oppenheimer added that a material impact to financials from the company's Agentforce artificial intelligence platform "is further out."

"Nevertheless, Agentforce is an investable theme, its commentary will likely be positive, and multiples already discount most of these risks," the firm said.

Oppenheimer maintained the company's outperform rating and $380 price target.

Price: 284.01, Change: +1.73, Percent Change: +0.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hubspot Insider Sold Shares Worth $1,424,150, According to a Recent SEC Filing
Hubspot Insider Sold Shares Worth $1,424,150, According to a Recent SEC Filing
Jun 3, 2024
03:52 AM EDT, 06/03/2024 (MT Newswires) -- Kathryn Bueker, Chief Financial Officer, on May 29, 2024, sold 2,191 shares in Hubspot ( HUBS ) for $1,424,150. Following the Form 4 filing with the SEC, Bueker has control over a total of 45,737 shares of the company, with 45,737 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1404655/000120919124005771/xslF345X03/doc4.xml Price: 612.00, Change: +0.95, Percent Change:...
Booz Allen Hamilton Holding Insider Sold Shares Worth $2,847,387, According to a Recent SEC Filing
Booz Allen Hamilton Holding Insider Sold Shares Worth $2,847,387, According to a Recent SEC Filing
Jun 3, 2024
03:50 AM EDT, 06/03/2024 (MT Newswires) -- Susan L Penfield, Executive Vice President & Chief Technology Officer, on May 30, 2024, sold 18,522 shares in Booz Allen Hamilton Holding ( BAH ) for $2,847,387. Following the Form 4 filing with the SEC, Penfield has control over a total of 33,788 shares of the company, with 33,788 shares held directly. SEC...
BioCryst Pharmaceuticals Says Drug Shows Evidence of Reducing Attacks Among Hereditary Angioedema Patients
BioCryst Pharmaceuticals Says Drug Shows Evidence of Reducing Attacks Among Hereditary Angioedema Patients
Jun 3, 2024
03:46 AM EDT, 06/03/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Sunday an analysis showed that six patients with hereditary angioedema experienced a reduction in monthly attacks while taking oral, once-daily Orladeyo. BioCryst said the data, presented at a conference in Spain, shows clinically relevant evidence that the drug, also known as berotralstat, can reduce the frequency and...
Morningstar Insider Sold Shares Worth $1,712,986, According to a Recent SEC Filing
Morningstar Insider Sold Shares Worth $1,712,986, According to a Recent SEC Filing
Jun 3, 2024
03:51 AM EDT, 06/03/2024 (MT Newswires) -- Joseph D Mansueto, 10% Owner, Director, Executive Chairman, on May 29, 2024, sold 5,964 shares in Morningstar ( MORN ) for $1,712,986. Following the Form 4 filing with the SEC, Mansueto has control over a total of 15,565,188 shares of the company, with 10,662,525 shares held directly and 4,902,663 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved